Jci_page_head_homepage_01 Jci_page_head_homepage_02
R. Gisli Jenkins, Xiao Su, George Su, Christopher J. Scotton, Eric Camerer, Geoffrey J. Laurent, George E. Davis, Rachel C. Chambers, Michael A. Matthay, Dean Sheppard
Published in Volume 116, Issue 6
J Clin Invest. 2006; 116(6):1606–1614 doi:10.1172/JCI27183
Abstract | Full text | PDF
Options: View larger image (or click on image)
Jci0627183
Figure 8
Par1–/– mice instilled with intratracheal bleomycin have reduced permeability and TGF-β activation compared with WT control.

(A) WT or Par1–/– mice were instilled with saline (Sal.; white bars) or 0.05 U bleomycin (Bleo.; black bars). ELW was measured as described. Bleomycin, n = 6; and saline, n = 5. (B) Quantification of nuclear localized phospho-Smad2 immunostaining in WT or Par1–/– mice instilled with saline (white bars) or 0.05 U bleomycin (black bars). WT mice, n = 4; Par1–/–, bleomycin, n = 4; and Par1–/–, saline, n = 3. (C) Representative histological sections showing nuclear localized phospho-Smad2 immunostaining in the lung of WT or Par1–/– mice. Original magnification, ×400. Values are presented as mean + SEM. #P < 0.005, *P < 0.05.